Article

Ophthalmologist travels to Zambia to help those in need

As physicians, my wife and I spent 2 weeks in Zambia with a group of 20 other professionals from the United States and United Kingdom. The expertise included banking, foundation management, real estate development, teaching, communications, and medicine.

The group went as Friends of Zambia, a non-profit organization. The mission of Friends of Zambia is to create interest in, understanding of, and investment with the people of Zambia.

The country is challenged by high unemployment, with only 300,000 taxpayers, plus nearly 70% of the population of Zambia is in poverty.

Perhaps most devastating is the HIV infection rate of Zambian population, at 16%. A young male has a 60% chance of dying of AIDS. Nearly every family in Zambia has a member infected with HIV/AIDS, leaving nearly 500,000 children as orphans.

Last year the UTH program administered 16,000 anti-retroviral (ARV) drug doses. These were mostly generic varieties from India. Although this program would like to deliver 100,000 doses next year, a shortage in supply will disappoint expectations.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.